SAN FRANCISCO and SUZHOU, China, March 2, 2026 -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic, and other major diseases, announces the non-covalent (reversible) Bruton's tyrosine kinase (BTK) inhibitor, Jaypirca® (pirtobrutinib), has received approval by the National Medical Products Administration (NMPA) in China for a new indication for the treatment of adult patients wit
The Future of Prostate Imaging: What do physicians want? MELBOURNE, Australia and INDIANAPOLIS, March 2, 2026 -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") invites investors to join a webinar with key opinion leaders to discuss a physician's perspective on innovations in PSMA-PET/CT imaging for prostate cancer. Speakers: Rodney Hicks, MD, Professor of Medicine at the University of Melbourne and Monash University; Founder, Executive Chairman and Chief Medical Officer at the Melbourne Theranostic Innovation Centre (MTIC
HONG KONG, March 1, 2026 -- Médecins Sans Frontières (MSF) Hong Kong successfully held its large‑scale running and orienteering competition, "On Track to Save 2026", today at the Hong Kong Science Park. The event saw its highest participation in recent years, with nearly 4,000 participants taking part in supporting medical humanitarian work. The well-loved orienteering competition also returned this year, receiving an overwhelming response. The family category alone attracted 149 teams, inspiring the next generation with the spirit of humanitarian aid. M
NEW YORK, Feb. 28, 2026 -- From February 26 to 27, the NPIAP 2026 Annual Conference was held in the United States, bringing together leading clinicians, researchers, and healthcare professionals to advance the prevention and management of pressure injuries. Dimora Medical, a continuous innovator in high-end medical care supplies, participated as the exclusive sponsor of the conference opening ceremony, joining the organizer in spotlighting pressure injury prevention, clinical best practices, and long-term support for affected patients and caregivers. The conference was organize
NEW YORK, Feb. 28, 2026 -- Since the launch of BestQool, this company has always aimed to deliver the most for its customers and continuously improve its home-use products, focusing on red light therapy devices. BestQool's executives carefully summarized feedback on the BQ60 and developed an improved version, the BQ60Pro. "BQ60's strong market performance proved the maturity and reliability of its core design framework," says Jacob, CEO of BestQool. "The BQ60Pro not only builds on that foundation with broader spectral distribution but, crucially, also gives our c
Patent leadership reinforces company's leading position in the global CBCT market HWASEONG, South Korea, Feb. 27, 2026 -- Vatech (KOSDAQ: 043150), a global manufacturer of dental imaging systems, announced that cumulative patent data over the past 20 years demonstrate its technological leadership in dental diagnostic imaging. Under the internationally recognized IPC classification A61B (medical diagnostics), Vatech ranked first in cumulative patent applications and granted patents among leading global dental diagnostic equipment manufacturers over the 2005–
SAN FRANCISCO, Feb. 27, 2026 -- European Wellness Biomedical Group, through its education division European Wellness Academy, is pleased to announce the official launch of "Concussion: The Hidden Trauma in Contact Sports and the NFL," co-authored by legendary NFL sports agent Leigh Steinberg and regenerative medicine pioneer Prof. Mike Chan, at the Brain Health Summit in San Francisco. The launch marked a defining moment in the global conversation surrounding concussion awareness, athlete safety, and long-term neurological health. Held during Steinberg's 39th Annual S
SHANGHAI, Feb. 27, 2026 -- WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug conjugates (ADCs) and other bioconjugates, today announced a strategic collaboration with Earendil Labs on WuXi XDC's proprietary WuXiTecan-2 payload-linker technology platform. Earendil Labs is an AI-powered biotech company focused on researching and developing next-generation innovative biologics for the treatment of autoimmune diseases, cancer, and other conditions with unmet medica
WILMINGTON, Del., Feb. 27, 2026 -- Earendil Labs, a global leader in AI-driven research and development of next-generation biologics therapeutics, today announced a strategic collaboration with WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK) on WuXi XDC's proprietary WuXiTecan-2 payload-linker technology platform. WuXi XDC Cayman Inc. (stock code: 2268.HK) is a globally recognized contract research, development, and manufacturing organization (CRDMO) specializing in bioconjugates. The company offers a wide range of innovative conjugation and payload-linker technologies to fac
SEOUL, South Korea, Feb. 27, 2026 -- Medit, a global provider of digital dentistry solutions, today announced that the "Glow Together" campaign will begin this March. The 'Glow Together' initiative began with small steps taken by the female employees of Medit. Light becomes more powerful when it is shared. Created in the spirit of International Women's Day, Glow Together is designed to spark connection across the dental community—and to translate participation into meaningful, real-world care beyond the clinic. While inspired by International Women's Day and t